arrow
H

Hong-Ming Hu

shanghai immunxell, ltd.
H指数:44
被引数:2.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phenotypic and clonal evolution of CD4 T cells in HNSCC during immunotherapy: a case report
2025-11-010
PRE
Identification of a TCR to a non-canonical peptide (NCP) presented by the autologous non-small cell lung cancer (NSCLC) following an immunotherapy that includes canonical and NCPs 3338
2025-11-010
PRE
An off-the-shelf multivalent vaccine containing cancer's dark matter, DPV-001, combined with PD-1+/- GITR in head & neck cancer: safety, efficacy, and immunodynamics from the phase 1 GITRVax trial
2024-04-050
PRE
Trial in progress: First-in-human immunotherapy-trio for advanced head and neck squamous cell carcinoma
2023-04-140
PRE